IOVA
Iovance Biotherapeutics
$4.90
−$0.09 (−1.8%)Jul 27, 2026
Key metrics
The numbers that frame IOVA today
- Market cap
- $2.19B
- P/E (TTM)
- -6.2
- EV / FCF
- -6.7
- Gross margin
- 36.7%
- EV / Sales
- 7.1
- ROIC
- -92.9%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $1.76
- 52wk High
- $5.64
Growth
Revenue and earnings trend for IOVA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about IOVA
Is Iovance Biotherapeutics a good buy?
Hold. Iovance Biotherapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case. We think Iovance Biotherapeutics is selling at a very high price.
What is the market capitalization of IOVA?
Iovance Biotherapeutics's market capitalization is $2.19B.
What is the P/E ratio for IOVA stock?
Iovance Biotherapeutics's current P/E ratio is -6.2.
What is the 52-week high for IOVA stock?
The 52-week high for Iovance Biotherapeutics is $5.64. The current close of $4.90 is 13.1% below that high.
What is the 52-week low for IOVA stock?
The 52-week low for Iovance Biotherapeutics is $1.76. The current close of $4.90 is 178.4% above that low.
Does IOVA stock pay dividends?
Iovance Biotherapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for IOVA?
Iovance Biotherapeutics's Debt / Equity ratio is 0.07.